Long‐acting β₂‐agonists

This publication has 38 references indexed in Scilit:

• Salmeterol in nocturnal asthma: a double blind, placebo controlled trial of a long acting inhaled beta 2 agonist.
  BMJ, 1990
• Protection against allergen-induced asthma by salmeterol
  The Lancet, 1990
• Increased bronchial hyperresponsiveness after inhaling salbutamol during 1 year is not caused by subsensitization to salbutamol1
  Journal of Allergy and Clinical Immunology, 1990
• Thermal Injury Effects on Drug Disposition: A Prospective Study with Piperacillin
  The Journal of Clinical Pharmacology, 1990
• Formoterol, a new long acting beta 2 agonist for inhalation twice daily, compared with salbutamol in the treatment of asthma.
  Thorax, 1990
• Formoterol, a new long-acting selective β-adrenergic receptor agonist: Double-blind comparison with salbutamol and placebo in children with asthma
  Journal of Allergy and Clinical Immunology, 1989
• Formoterol fumarate, a new β₂‐adrenoceptor agonist
  Allergy, 1989
• Salmeterol, a new long acting inhaled beta 2 adrenoceptor agonist: comparison with salbutamol in adult asthmatic patients.
  Thorax, 1988
• Effect of long-term treatment with inhaled corticosteroids and beta-agonists on the bronchial responsiveness in children with asthma
  Journal of Allergy and Clinical Immunology, 1987
• Changes in bronchial hyperreactivity induced by 4 weeks of treatment with antiasthmatic drugs in patients with allergic asthma: A comparison between budesonide and terbutaline
  Journal of Allergy and Clinical Immunology, 1985